Literature DB >> 7687847

Structure of the human arylsulfatase B gene.

S Modaressi1, K Rupp, K von Figura, C Peters.   

Abstract

We have isolated lambda-phage clones containing the human arylsulfatase B gene region from a genomic lambda 47.1 library. The human arylsulfatase B gene comprises 8 exons interrupted by 7 introns. DNA sequences of all intron-exon boundaries and the 5' flanking region of the gene were determined. All intron-exon splice junctions conformed to the GT/AG consensus sequence. Primer extension analysis revealed multiple start sites 1 to 135 nucleotides 5' of the ATG translational start codon. A 398 bp DNA-fragment of the 5' flanking region exhibits promotor activity when transiently expressed in BHK-21 cells using the bacterial chloramphenicol acetyltransferase gene as a reporter gene. This putative promotor region is located in a CpG island and contains potential Sp1 and AP2 binding sites but lacks typical TATA and CAAT box motifs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687847     DOI: 10.1515/bchm3.1993.374.1-6.327

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  11 in total

1.  Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients.

Authors:  M F G Petry; K Nonemacher; J C Sebben; I V D Schwartz; A C M Azevedo; M G Burin; A R de Rezende; C A Kim; R Giugliani; S Leistner-Segal
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI.

Authors:  M Evers; P Saftig; P Schmidt; A Hafner; D B McLoghlin; W Schmahl; B Hess; K von Figura; C Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy.

Authors:  C Fillat; C M Simonaro; P L Yeyati; J L Abkowitz; M E Haskins; E H Schuchman
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Four novel mutant alleles of the arylsulfatase B gene in two patients with intermediate form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

Authors:  E Voskoboeva; D Isbrandt; K von Figura; X Krasnopolskaya; C Peters
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

5.  Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes.

Authors:  D Isbrandt; G Arlt; D A Brooks; J J Hopwood; K von Figura; C Peters
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

6.  Molecular Analysis of Turkish Maroteaux-Lamy Patients and Identification of One Novel Mutation in the Arylsulfatase B (ARSB) Gene.

Authors:  Alessandra Zanetti; Neslihan Onenli-Mungan; Nursel Elcioglu; Mehmet Nuri Ozbek; Deniz Kör; Elisabetta Lenzini; Maurizio Scarpa; Rosella Tomanin
Journal:  JIMD Rep       Date:  2013-11-16

7.  Compound heterozygous missense mutations in a Chinese mucopolysaccharidosis type VI patient: a case report.

Authors:  Ming-Fang He; Ji Yang; Meng-Jie Dong; Yin-Ting Wang; Hai Liu
Journal:  BMC Ophthalmol       Date:  2021-05-13       Impact factor: 2.209

Review 8.  Diagnostic and treatment strategies in mucopolysaccharidosis VI.

Authors:  Filippo Vairo; Andressa Federhen; Guilherme Baldo; Mariluce Riegel; Maira Burin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Appl Clin Genet       Date:  2015-10-30

9.  Novel mutations of the arylsulphatase B (ARSB) gene in Indian patients with mucopolysaccharidosis type VI.

Authors:  Anusha Uttarilli; Prajnya Ranganath; S Jamal Md Nurul Jain; C Krishna Prasad; Anupam Sinha; Ishwar C Verma; Shubha R Phadke; Ratna D Puri; Sumita Danda; Mamta N Muranjan; Ganesh Jevalikar; H A Nagarajaram; Ashwin B Dalal
Journal:  Indian J Med Res       Date:  2015-10       Impact factor: 2.375

Review 10.  Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know.

Authors:  Mirella Filocamo; Rosella Tomanin; Francesca Bertola; Amelia Morrone
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.